The Pfizer COVID-19 vaccine is preferred by Australians under the age of 50 after the association between AstraZeneca injections and rare blood clots has been identified.
Chief Medical Officer Paul Kelly said Thursday night that the Australian Technical Advisory Group had met after the European authorities confirmed the link, favoring adults under the age of 50 who have not yet received the first AstraZeneca dose of the Pfizer vaccine. Was recommended.
According to Professor Kelly, adults under the age of 50 should be first vaccinated with the AstraZeneca COVID-19 vaccine only in situations where the individual’s benefits clearly outweigh the risks.
He said that people who took the first AstraZeneca without serious side effects could safely take the second.
Health ministry Secretary Brendan Murphy emphasized that blood clots are a “very rare event” and that Australia is in a “very preventative position.”
“This syndrome looks like a real syndrome as a result of all the work done in the UK and Europe. Considering that this syndrome seems to occur primarily in young people, it’s enough. With caution, I now feel that the risk of severe COVID is not very high, so there is evidence that there are recommendations recommended for people under the age of 50, “Dr. Murphy said.
“We highly recommend AstraZeneca vaccination for people over the age of 50. It is a very effective vaccine to prevent severe COVID.
“The risk is very low.”
I will come more.